Skip to content

STUDY OF PREFERENCES IN MEN FACED WITH THE DIFFERENT TREATMENT OPTIONS FOR LOCALIZED PROSTRATE CANCER WITH A GOOD OR INTERMEDIATE PROGNOSIS

STUDY OF PREFERENCES IN MEN FACED WITH THE DIFFERENT TREATMENT OPTIONS FOR LOCALIZED PROSTRATE CANCER WITH A GOOD OR INTERMEDIATE PROGNOSIS

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02080793
Acronym
CALIPSO
Enrollment
652
Registered
2014-03-06
Start date
2013-05-25
Completion date
Unknown
Last updated
2019-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients Seen at a Urology Consultation

Brief summary

This study will be based on two questionnaires 1. One specific questionnaire that has already been developed from social sciences interviews conducted in men who have been treated for localized prostrate cancer, with a good or intermediate prognosis. This questionnaire comprises 11 pairs of scenarios. Each scenario gathers in a random manner, the modalities of 7 possible characteristics of the management strategy for localized prostrate cancer, with a good or intermediate prognosis: * the risk of death at 5 years (modalities: 5%, 15%), * the risk of impotence (modalities: 0%, 25%, 50%, 75%), * the presence of urinary leaks (modalities: no protection during the day, one protection pad per day, several protection pads per day), * the duration and frequency of care provided (modalities: 2 days of care in your whole life, 7 days of care in your whole life, 5 half-days of care per week for 8 weeks, every 3 months for 2 years then every 6 months for life), * ablation of the prostate (modalities: Yes, No), * the existence of possible treatments in case of aggravation or recurrence (modalities: Yes, No), * the nature of the technology used (modalities: innovative technology, standard technology). The objective is to ask each participant of the study for each pair of scenarios, to choose from the two scenarios (binary-choice survey), the scenario he prefers. 2. The Spielberger Inventory Trait scale to evaluate stable characteristics in the propensity to anxiety in study participants.

Interventions

OTHERQuestionnaire

Sponsors

Centre Hospitalier Universitaire Dijon
Lead SponsorOTHER

Study design

Primary purpose
OTHER

Eligibility

Sex/Gender
ALL
Age
50 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

Men: * aged 50 to 70 years * seen at a urology consultation * able to understand written and spoken French * who have provided written informed consent

Exclusion criteria

Men: * under guardianship or wards of court * who have already been diagnosed withor treated for prostrate cancer * with recently diagnosed cancer or on treatment for this cancer

Design outcomes

Primary

MeasureTime frame
Identification of personal factors linked to the management strategy chosen with regard to the preferences of patients.Baseline

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026